News
An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...
1h
InvestorsHub on MSNGSK shares rise after FDA grants priority review for oral gonorrhea antibiotic
GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...
GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...
Chasing a 100 times return might not be a great idea. But there are lessons to be taken from past winners of this magnitude.
Here are two beaten-down stocks that long-term investors might want to consider buying on the dip and holding for several ...
Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results